<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Emerg Infect Dis</journal-id>
      <journal-id journal-id-type="iso-abbrev">Emerging Infect. Dis</journal-id>
      <journal-id journal-id-type="publisher-id">EID</journal-id>
      <journal-title-group>
        <journal-title>Emerging Infectious Diseases</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1080-6040</issn>
      <issn pub-type="epub">1080-6059</issn>
      <publisher>
        <publisher-name>Centers for Disease Control and Prevention</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25897877</article-id>
      <article-id pub-id-type="pmc">4412226</article-id>
      <article-id pub-id-type="publisher-id">14-1610</article-id>
      <article-id pub-id-type="doi">10.3201/eid2105.141610</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letters to the Editor</subject>
        </subj-group>
        <subj-group subj-group-type="article-type">
          <subject>Letter</subject>
        </subj-group>
        <subj-group subj-group-type="TOC-title">
          <subject>Melioidosis in Trinidad and Tobago</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Melioidosis in Trinidad and Tobago</article-title>
        <alt-title alt-title-type="running-head">Melioidosis in Trinidad and Tobago</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Hogan</surname>
            <given-names>Catherine</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wilmer</surname>
            <given-names>Amanda</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Badawi</surname>
            <given-names>Mazen</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hoang</surname>
            <given-names>Linda</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chapman</surname>
            <given-names>Michael</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Press</surname>
            <given-names>Natasha</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Antonation</surname>
            <given-names>Kym</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Corbett</surname>
            <given-names>Cindi</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Romney</surname>
            <given-names>Marc</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Murray</surname>
            <given-names>Melanie</given-names>
          </name>
        </contrib>
        <aff id="aff1">University of Sherbrooke, Sherbrooke, Quebec, Canada (C. Hogan); </aff>
        <aff id="aff2">University of British Columbia, Vancouver, British Columbia, Canada (A. Wilmer, M. Badawi, L. Hoang, M. Chapman, N. Press, M. Romney, M. Murray); </aff>
        <aff id="aff3">King Abdulaziz University, Jeddah, Saudi Arabia (M. Badawi); </aff>
        <aff id="aff4">British Columbia Centre for Disease Control Public Health Microbiology and Reference Laboratory, Vancouver (L. Hoang); </aff>
        <aff id="aff5">St. Paul&#x2019;s Hospital, Vancouver (N. Press, M. Romney, M. Murray); </aff>
        <aff id="aff6">National Microbiology Laboratory, Winnipeg, Manitoba, Canada (K. Antonation, C. Corbett); </aff>
        <aff id="aff7">British Columbia Women&#x2019;s Hospital, Vancouver (M. Murray)</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1">Address for correspondence: Melanie Murray, BC Women&#x2019;s Hospital &amp; Health Centre, E600B, 4500 Oak St, Vancouver, BC V6H 3N1, Canada; email: <email xlink:href="Melanie.Murray@cw.bc.ca">Melanie.Murray@cw.bc.ca</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>5</month>
        <year>2015</year>
      </pub-date>
      <volume>21</volume>
      <issue>5</issue>
      <fpage>902</fpage>
      <lpage>904</lpage>
      <kwd-group kwd-group-type="author">
        <title>Keywords: </title>
        <kwd>
          <italic>Burkholderia pseudomallei</italic>
        </kwd>
        <kwd>melioidosis</kwd>
        <kwd>epidemiology</kwd>
        <kwd>Trinidad and Tobago</kwd>
        <kwd>bacteria</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p><bold>To the Editor:</bold> Melioidosis refers to infection caused by the facultative intracellular gram-negative bacterium <italic>Burkholderia pseudomallei</italic>. The clinical manifestations of melioidosis span a wide spectrum, from asymptomatic exposure or localized cutaneous infection to septic shock with multiorgan failure. Melioidosis usually occurs in residents of or travelers to disease-endemic areas in northern Australia and Southeast Asia; however, an increasing number of confirmed melioidosis cases are being reported from the Caribbean. We report a case of melioidosis acquired in Trinidad and Tobago.</p>
    <p>In February 2014, a 17-year-old male student was admitted to a tertiary care hospital in Vancouver, British Columbia, Canada, with catecholaminergic polymorphic ventricular tachycardia and electrical storm. He had a 9-month history of dry cough that was unresponsive to multiple and prolonged courses of treatment for community-acquired pneumonia. During the 6 months before his admission, the patient had hemoptysis and radiologic evidence of pneumonia that were treated with courses of cephalosporins without resolution of symptoms. Bronchoscopy and culture of lavage samples had revealed infection with <italic>Staphylococcus aureus</italic> and an organism most closely related to <italic>Actinomyces graevenitzii</italic>
<italic>.</italic></p>
    <p>The patient had no history indicative of risk factors for recurrent sinusitis or pneumonia (e.g., cystic fibrosis, chronic granulatomous disease, Job syndrome), and no risk factors for tuberculosis or infection with dimorphic fungi. He was up to date on his vaccinations and had no pets. He was born in Jamaica, had moved to Canada at age 4, and had not traveled anywhere other than Trinidad and Tobago, Canada, and England. He had traveled to visit family in Trinidad for 2 months during the rainy season in 2012, at which time he also visited Tobago.</p>
    <p>On day 5 of hospital admission, the patient became febrile (39.6&#xB0;C), and an infectious diseases specialist was consulted. Examination revealed that the patient was clinically stable but emaciated at 45 kg. His oxygen saturation while breathing room air was 98%. Physical examination, including cardiorespiratory examination, was unremarkable. Laboratory results showed a normal hemoglobin concentration of 133 g/L; elevated leukocyte count of 22.8 &#xD7; 10<sup>9</sup> cells/L; neutrophils 19.4 &#xD7; 10<sup>9</sup> cells/L; normal platelet count of 295 &#xD7; 10<sup>9</sup>/L; and normal creatinine of 54 &#x3BC;mol/L. Test results for HIV-1 and blood cultures were negative. Computed tomography scan showed dilated bronchi and dense consolidation of the right and left lower lobes. Piperacillin/tazobactam was started for presumed hospital-acquired pneumonia.</p>
    <p>The patient underwent diagnostic bronchoscopy with bronchoalveolar lavage. Gram staining of specimens showed occasional gram-negative bacilli, and aerobic cultures grew gram-negative bacilli. Further testing with the Vitek 2 (bioM&#xE9;rieux, Laval, Quebec, Canada) (96%) and RapID NF (Oxoid, Nepean, Ontario, Canada) (99.9%) systems identified <italic>B. pseudomallei</italic>, but matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (Vitek MS, bioM&#xE9;rieux) did not. Phenotypic confirmation was performed at the provincial public health and reference laboratory. Antimicrobial drug susceptibility testing performed by broth microdilution according to Clinical and Laboratory Standards Institute recommendations (<xref rid="R1" ref-type="bibr"><italic>1</italic></xref>) and by Etest (bioM&#xE9;rieux) showed susceptibility to amoxicillin/clavulanic acid, ceftazidime, imipenem, doxycycline, and trimethoprim/sulfamethoxazole. The patient&#x2019;s condition improved after 2 weeks of intravenous meropenem, and antimicrobial therapy was changed to oral trimethoprim/sulfamethoxazole.</p>
    <p>The <italic>B. pseudomallei</italic> isolate was sent to the Public Health Agency of Canada&#x2019;s National Microbiology Laboratory for molecular typing. Query of 7 standard multilocus sequence typing loci (<ext-link ext-link-type="uri" xlink:href="http://bpseudomallei.mlst.net/">http://bpseudomallei.mlst.net/</ext-link>) identified the isolate as a novel multilocus sequence type. The sequence type (1,1,2,1,5,6,1) closely resembled that of <italic>B. pseudomallei</italic> previously isolated from the Caribbean (<xref rid="R2" ref-type="bibr"><italic>2</italic></xref>).</p>
    <p>Although melioidosis was first described in the Caribbean in 1947 (<xref rid="R3" ref-type="bibr"><italic>3</italic></xref>), most case reports of the disease in the area are from the past 2 decades. This case report suggests progression of the range of melioidosis to include Trinidad and Tobago. A recent study documented the presence of <italic>B. pseudomallei</italic> in soil samples and high seroprevalence rates among contacts of persons with melioidosis in Puerto Rico (<xref rid="R4" ref-type="bibr"><italic>4</italic></xref>)<italic>.</italic> If examined, this pattern of regional melioidosis endemicity may also be found on other Caribbean islands.</p>
    <p>Increased clinical awareness of and improved surveillance for <italic>B. pseudomallei</italic> infection may partly explain emergence. Nonetheless, underascertainment probably occurs in rural areas with limited access to advanced diagnostic support and in urban areas when <italic>B. pseudomallei</italic> infection is not suspected because of lack of travel to classic disease-endemic areas. Because <italic>B. pseudomallei</italic> is a Biosafety Level 3 agent, when infectious disease specialists consider melioidosis in their differential diagnoses, they should alert the microbiology laboratory to confirm species identification and ensure that staff use proper biosafety measures.</p>
    <p>A total of 19 cases of melioidosis acquired in the Caribbean have been reported (<xref ref-type="table" rid="T1">Table</xref>). Nine of these were travel related, suggesting that melioidoisis may be emerging as a travel health issue. Travelers with known risk factors for melioidosis, such as diabetes mellitus and chronic lung disease, should be informed of their increased infection risk. Physicians should include <italic>B. pseudomallei</italic> in the differential diagnosis of travelers with pneumonia or sepsis who are returning from the Caribbean, particularly when they have a history of travel during the rainy season, soil-contaminated wounds, or known risk factors for melioidosis.</p>
    <table-wrap id="T1" position="float">
      <label>Table</label>
      <caption>
        <title>Published case reports of melioidosis from the Caribbean*</title>
      </caption>
      <table frame="hsides" rules="groups">
        <col width="29" span="1"/>
        <col width="49" span="1"/>
        <col width="27" span="1"/>
        <col width="54" span="1"/>
        <col width="54" span="1"/>
        <col width="63" span="1"/>
        <col width="72" span="1"/>
        <col width="94" span="1"/>
        <col width="38" span="1"/>
        <thead>
          <tr>
            <th valign="bottom" align="left" scope="col" rowspan="1" colspan="1">Ref. </th>
            <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Site of origin (year)</th>
            <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Age, y/sex</th>
            <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Type of exposure</th>
            <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Concurrent condition</th>
            <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Clinical manifestation</th>
            <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Diagnostic method</th>
            <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Treatment&#x2028;(duration)</th>
            <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Outcome</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">(<xref rid="R3" ref-type="bibr"><italic>3</italic></xref>)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Panama (1947)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">31/M</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Fall on buttock, TR</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Polio, spinal meningitis</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Buttock abscess</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Abscess culture</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Sulfathiazole, sulfapyridine, streptomycin, penicillin</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Survived</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">(<xref rid="R5" ref-type="bibr"><italic>5</italic></xref>)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Panama (1948)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">25/F</td>
            <td valign="top" align="center" rowspan="1" colspan="1">UNK, TR</td>
            <td valign="top" align="center" rowspan="1" colspan="1">None</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Retroperitoneal abscess, sepsis</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Abscess culture</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Penicillin, streptomycin</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Died</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">(<xref rid="R5" ref-type="bibr"><italic>5</italic></xref>)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Panama (1960)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">20/M</td>
            <td valign="top" align="center" rowspan="1" colspan="1">UNK</td>
            <td valign="top" align="center" rowspan="1" colspan="1">None</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Acute septic arthritis</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Synovial fluid culture</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Chloramphenicol, novobiocin, sulfisoxazole</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Survived</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">(<xref rid="R5" ref-type="bibr"><italic>5</italic></xref>)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Puerto Rico (1982)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">62/F</td>
            <td valign="top" align="center" rowspan="1" colspan="1">UNK</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Diabetes, SLE, cirrhosis</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Septic meningitis</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Blood and CSF culture</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Penicillin, chloramphenicol, moxalactam, amikacin</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Died</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">(<xref rid="R5" ref-type="bibr"><italic>5</italic></xref>)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Mexico (1986)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">72/M</td>
            <td valign="top" align="center" rowspan="1" colspan="1">UNK</td>
            <td valign="top" align="center" rowspan="1" colspan="1">None</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Pneumonia, splenic abscess</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Blood and sputum culture</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Cefoxitin, gentamicin</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Died</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">(<xref rid="R5" ref-type="bibr"><italic>5</italic></xref>)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Martinique (1995)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">66/M</td>
            <td valign="top" align="center" rowspan="1" colspan="1">UNK, resident</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Diabetes</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Sepsis</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Blood and urine culture</td>
            <td valign="top" align="center" rowspan="1" colspan="1">IV ceftazidime, then oral TMP/SMX and doxycycline (2 mo)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Survived</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">(<xref rid="R5" ref-type="bibr"><italic>5</italic></xref>)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Guadeloupe (1997)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">4/M</td>
            <td valign="top" align="center" rowspan="1" colspan="1">UNK, TR</td>
            <td valign="top" align="center" rowspan="1" colspan="1">None</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Pneumonia, pleural effusion, peritonitis</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Pleural fluid culture</td>
            <td valign="top" align="center" rowspan="1" colspan="1">IV ceftazidime and TMP/SMX(1 mo), then oral TMP/SMX (6 mo)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Survived</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">(<xref rid="R5" ref-type="bibr"><italic>5</italic></xref>)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Puerto Rico (1997)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">11/M</td>
            <td valign="top" align="center" rowspan="1" colspan="1">UNK, resident</td>
            <td valign="top" align="center" rowspan="1" colspan="1">X-linked CGD</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Mediastinitis, lymphadenitis</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Supraclavicular and hilar biopsy culture</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Imipenem and doxycycline (6 weeks), oral cefixime and doxycycline (3 wk)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Died&#x2020;</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">(<xref rid="R5" ref-type="bibr"><italic>5</italic></xref>)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">El Salvador (2001)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">UNK</td>
            <td valign="top" align="center" rowspan="1" colspan="1">UNK, TR</td>
            <td valign="top" align="center" rowspan="1" colspan="1">UNK</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Cerebral abscess</td>
            <td valign="top" align="center" rowspan="1" colspan="1">UNK</td>
            <td valign="top" align="center" rowspan="1" colspan="1">UNK</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Survived</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">(<xref rid="R4" ref-type="bibr"><italic>4</italic></xref>)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Puerto Rico (2003)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">55/F</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Flood water, resident</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Diabetes</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Pneumonia, septic shock</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Blood and sputum culture</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Imipenum, amikacin, azithromycin</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Died</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">(<xref rid="R6" ref-type="bibr"><italic>6</italic></xref>)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">British Virgin Islands (2006)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">17/M</td>
            <td valign="top" align="center" rowspan="1" colspan="1">UNK, resident</td>
            <td valign="top" align="center" rowspan="1" colspan="1">CF</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Pneumonia</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Sputum culture,&#x2028;PCR</td>
            <td valign="top" align="center" rowspan="1" colspan="1">UNK</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Survived</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">(<xref rid="R7" ref-type="bibr"><italic>7</italic></xref>)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Aruba (2009)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">7/F</td>
            <td valign="top" align="center" rowspan="1" colspan="1">UNK, TR</td>
            <td valign="top" align="center" rowspan="1" colspan="1">CF</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Pneumonia</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Oropharyngeal and induced sputum culture</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Imipenem and ceftazidime (14 d), then inhaled meropenem (28 d) and long-term oral TMP/SMX</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Survived</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">(<xref rid="R4" ref-type="bibr"><italic>4</italic></xref>)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Puerto Rico (2009)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">88/M</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Ditch digging, resident</td>
            <td valign="top" align="center" rowspan="1" colspan="1">CAD, PVD</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Pneumonia</td>
            <td valign="top" align="center" rowspan="1" colspan="1">MLST</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Doxycycline (20 wk), oral TMP/SMX</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Survived</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">(<xref rid="R8" ref-type="bibr"><italic>8</italic></xref>)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Guadeloupe (2010)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">15/F</td>
            <td valign="top" align="center" rowspan="1" colspan="1">UNK, TR</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Asthma, dengue fever</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Adenopathy, tumefaction</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Tumefaction culture&#x2028;PCR</td>
            <td valign="top" align="center" rowspan="1" colspan="1">IV ceftazidime (10 d), then oral TMP/SMX (12 wk)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Survived</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">(<xref rid="R9" ref-type="bibr"><italic>9</italic></xref>)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Martinique (2010)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">35/M</td>
            <td valign="top" align="center" rowspan="1" colspan="1">UNK, TR</td>
            <td valign="top" align="center" rowspan="1" colspan="1">None</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Diarrhea, pneumonia</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Blood culture;&#x2028;PCR</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Imipenem,&#x2028;G-CSF</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Died</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">(<xref rid="R10" ref-type="bibr"><italic>10</italic></xref>)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Aruba (2012)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">46/F</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Water exposure, TR</td>
            <td valign="top" align="center" rowspan="1" colspan="1">None</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Breast abscesses</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Abscess culture</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Meropenem (14 d), then oral TMP/SMX (12 wk)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Survived</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">(<xref rid="R4" ref-type="bibr"><italic>4</italic></xref>)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Puerto Rico (2010)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">38/M</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Landscaping, resident</td>
            <td valign="top" align="center" rowspan="1" colspan="1">None</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Pneumonia, hepatitis, myocarditis, septic shock</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Immunohistochemistry with polyclonal Ab; PCR</td>
            <td valign="top" align="center" rowspan="1" colspan="1">None</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Died</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">(<xref rid="R4" ref-type="bibr"><italic>4</italic></xref>)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Puerto Rico (2012)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">60/M</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Agricultural work, resident</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Diabetes</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Diabetic ketoacidosis</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Blood culture; MLST</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Amoxicillin/cloxacillin (10 d), then oral TMP/SMX (12 weeks)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Survived</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">This study</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Trinidad and Tobago (2014)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">17/M</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Rainy season, TR</td>
            <td valign="top" align="center" rowspan="1" colspan="1">CPVT</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Chronic pneumonia</td>
            <td valign="top" align="center" rowspan="1" colspan="1">BAL culture; MLST</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Meropenem (2 weeks), then oral TMP/SMX (8 mo to date)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Survived</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <p>*Ab, antibody; BAL, bronchoalveolar lavage; CAD, coronary artery disease; CGD, chronic granulomatous disease; CPVT, catecholaminergic polymorphic ventricular tachycardia; CSF, cerebrospinal fluid; G-CSF, granulocyte colony-stimulating factor; IV, intravenous; MLST, multilocus sequence typing; PVD, peripheral vascular disease; Ref., reference; SLE, systemic lupus erythematosus; TMP/SMX, trimethoprim/sulfamethoxazole; TR, travel related; UNK, unknown.&#x2028;&#x2020;Cause of death unknown.</p>
      </table-wrap-foot>
    </table-wrap>
  </body>
  <back>
    <fn-group>
      <fn fn-type="citation">
        <p><italic>Suggested citation for this article</italic>: Hogan C, Wilmer A, Badawi M, Hoang L, Chapman M, Press N, et al. Melioidosis in Trinidad and Tobago. Emerg Infect Dis. 2015 May [<italic>date cited</italic>]. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3201/eid2105.141610">http://dx.doi.org/10.3201/eid2105.141610</ext-link></p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgment</title>
      <p>We thank the National Microbiology Laboratory for confirming the identification of the <italic>B. pseudomallei</italic> isolate and performing molecular testing and antimicrobial susceptibility testing.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="R1">
        <label>1. </label>
        <mixed-citation publication-type="book">Clinical and Laboratory Standards Institute. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria. CLSI document M45-A2. 2nd ed. Wayne (PA): The Institute; <year>2010</year>. </mixed-citation>
      </ref>
      <ref id="R2">
        <label>2. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Godoy</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Randle</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Simpson</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Aanensen</surname>
<given-names>DM</given-names></string-name>, <string-name><surname>Pitt</surname>
<given-names>TL</given-names></string-name>, <string-name><surname>Kinoshita</surname>
<given-names>R</given-names></string-name>, <etal/>
<article-title>Multilocus sequence typing and evolutionary relationships among the causative agents of melioidosis and glanders, <italic>Burkholderia pseudomallei</italic> and <italic>Burkholderia mallei</italic>.</article-title>
<source>J Clin Microbiol</source>. <year>2003</year>;<volume>41</volume>:<fpage>2068</fpage>&#x2013;<lpage>79</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.41.5.2068-2079.2003</pub-id><pub-id pub-id-type="pmid">12734250</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3. </label>
        <mixed-citation publication-type="journal"><string-name><surname>McDowell</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Varney</surname>
<given-names>PL</given-names></string-name>. <article-title>Melioidosis, report of first case from the Western Hemisphere.</article-title>
<source>J Am Med Assoc</source>. <year>1947</year>;<volume>134</volume>:<fpage>361</fpage>. <pub-id pub-id-type="doi">10.1001/jama.1947.72880210001008</pub-id><pub-id pub-id-type="pmid">20239027</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Doker</surname>
<given-names>TJ</given-names></string-name>, <string-name><surname>Sharp</surname>
<given-names>TM</given-names></string-name>, <string-name><surname>Rivera-Garcia</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Perez-Padilla</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Benoit</surname>
<given-names>TJ</given-names></string-name>, <string-name><surname>Ellis</surname>
<given-names>EM</given-names></string-name>, <etal/>
<article-title>Contact investigation of melioidosis cases reveals regional endemicity in Puerto Rico.</article-title>
<source>Clin Infect Dis</source>. <year>2015</year>;<volume>60</volume>:<fpage>243</fpage>&#x2013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1093/cid/ciu764</pub-id><pub-id pub-id-type="pmid">25270646</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Inglis</surname>
<given-names>TJ</given-names></string-name>, <string-name><surname>Rolim</surname>
<given-names>DB</given-names></string-name>, <string-name><surname>Sousa Ade</surname>
<given-names>Q</given-names></string-name>. <article-title>Melioidosis in the Americas.</article-title>
<source>Am J Trop Med Hyg</source>. <year>2006</year>;<volume>75</volume>:<fpage>947</fpage>&#x2013;<lpage>54</lpage>.<pub-id pub-id-type="pmid">17123994</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Corral</surname>
<given-names>DM</given-names></string-name>, <string-name><surname>Coates</surname>
<given-names>AL</given-names></string-name>, <string-name><surname>Yau</surname>
<given-names>YC</given-names></string-name>, <string-name><surname>Tellier</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Glass</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Jones</surname>
<given-names>SM</given-names></string-name>, <etal/>
<article-title><italic>Burkholderia pseudomallei</italic> infection in a cystic fibrosis patient from the Caribbean: a case report.</article-title>
<source>Can Respir J</source>. <year>2008</year>;<volume>15</volume>:<fpage>237</fpage>&#x2013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">18716683</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7. </label>
        <mixed-citation publication-type="journal"><string-name><surname>O&#x2019;Sullivan</surname>
<given-names>BP</given-names></string-name>, <string-name><surname>Torres</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Conidi</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Smole</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Gauthier</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Stauffer</surname>
<given-names>KE</given-names></string-name>, <etal/>
<article-title><italic>Burkholderia pseudomallei</italic> infection in a child with cystic fibrosis: acquisition in the Western Hemisphere.</article-title>
<source>Chest</source>. <year>2011</year>;<volume>140</volume>:<fpage>239</fpage>&#x2013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1378/chest.10-3336</pub-id><pub-id pub-id-type="pmid">21729895</pub-id></mixed-citation>
      </ref>
      <ref id="R8">
        <label>8. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Meckenstock</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Therby</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Marque-Juillet</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Monnier</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Khau</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Pangon</surname>
<given-names>B</given-names></string-name>, <etal/>
<article-title>Cutaneous melioidosis in adolescent returning from Guadeloupe.</article-title>
<source>Emerg Infect Dis</source>. <year>2012</year>;<volume>18</volume>:<fpage>359</fpage>&#x2013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.3201/eid1802111603</pub-id><pub-id pub-id-type="pmid">22305492</pub-id></mixed-citation>
      </ref>
      <ref id="R9">
        <label>9. </label>
        <mixed-citation publication-type="journal"><string-name><surname>G&#xE9;taz</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Abbas</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Loutan</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Schrenzel</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Iten</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Simon</surname>
<given-names>F</given-names></string-name>, <etal/>
<article-title>Fatal acute melioidosis in a tourist returning from Martinique Island, November 2010.</article-title>
<source>Euro Surveill</source>. <year>2011</year>;<volume>16</volume>:<fpage>19758</fpage>.<pub-id pub-id-type="pmid">21223835</pub-id></mixed-citation>
      </ref>
      <ref id="R10">
        <label>10. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Mickail</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Klein</surname>
<given-names>NC</given-names></string-name>, <string-name><surname>Cunha</surname>
<given-names>BA</given-names></string-name>, <string-name><surname>Schoch</surname>
<given-names>PA</given-names></string-name>. <article-title>Melioidosis breast abscesses.</article-title>
<source>J Infect</source>. <year>2012</year>;<volume>64</volume>:<fpage>434</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/j.jinf.2011.12.016</pub-id><pub-id pub-id-type="pmid">22285589</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
